Selected article for: "ACTH adrenocorticotropic hormone and adrenocorticotropic hormone"

Author: Kumar, Bharat; Gopalakrishnan, Maya; Garg, Mahendra Kumar; Purohit, Purvi; Banerjee, Mithu; Sharma, Praveen; Khichar, Satyendra; Kothari, Nikhil; Bhatia, Pradeep; Nag, Vijay Lakshmi; Misra, Sanjeev
Title: Endocrine Dysfunction among Patients with COVID-19: A Single-center Experience from a Tertiary Hospital in India
  • Cord-id: 6xv6tjj1
  • Document date: 2021_7_21
  • ID: 6xv6tjj1
    Snippet: OBJECTIVE: COVID-19 has emerged as a multi-system disease with the potential for endocrine dysfunction. We aimed to study the hormonal profile of hospitalized patients with COVID-19 at a tertiary care referral hospital at Jodhpur, India. DESIGN: A hospital-based clinical study of endocrine profile of COVID-19 patients conducted from 15(th) May to 30(th) June 2020 after ethical approval. MEASUREMENTS: Fasting blood samples for free thyroxine (T4), free tri-iodothyronine (T3), thyroid stimulating
    Document: OBJECTIVE: COVID-19 has emerged as a multi-system disease with the potential for endocrine dysfunction. We aimed to study the hormonal profile of hospitalized patients with COVID-19 at a tertiary care referral hospital at Jodhpur, India. DESIGN: A hospital-based clinical study of endocrine profile of COVID-19 patients conducted from 15(th) May to 30(th) June 2020 after ethical approval. MEASUREMENTS: Fasting blood samples for free thyroxine (T4), free tri-iodothyronine (T3), thyroid stimulating Hormone (TSH), serum prolactin; basal and 1 h post-intramuscular adrenocorticotropic hormone (ACTH) stimulated cortisol, interleukin-6 (IL-6), and high sensitivity C-reactive protein (hsCRP) were collected within 24 h of admission after written informed consent. All hormones and IL-6 were analyzed by chemiluminescent immunoassay. hsCRP was measured by immune-turbidimetric assay. RESULTS: Of 235 patients studied, 14% had severe disease and 5.5% died. Adrenal insufficiency was present in 14%, most of whom had mild disease. A robust adrenal response was observed in those with severe disease. Basal and post-ACTH serum cortisol were significantly increased in severe disease or those who died compared to those who were mild or asymptomatic. Basal and post-ACTH serum cortisol showed a significant positive correlation with hsCRP but not with IL-6. Low T3 and low T4 syndrome were documented in 25% and 5%, respectively. Serum TSH and FT3 levels declined significantly from asymptomatic to severe category. Hyperprolactinemia was found in 21 patients. hsCRP showed a rising trend with disease severity while IL-6 did not. CONCLUSIONS: Endocrine dysfunction in the form of adrenal insufficiency, low T3, and low TSH syndrome and hyperprolactinemia were common COVID-19 hospitalized patients.

    Search related documents:
    Co phrase search for related documents
    • acth antibody and adrenal thyroid: 1
    • acth cortisol and acute respiratory syndrome: 1, 2
    • acth cortisol and adrenal insufficiency: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acth cortisol and adrenal insufficiency present: 1
    • acth cortisol and adrenal pituitary: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acth cortisol and adrenal pituitary hypothalamic: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acth cortisol and adrenal thyroid: 1, 2
    • acth cortisol level and adrenal insufficiency: 1, 2
    • acth cortisol level and adrenal pituitary: 1
    • acth cortisol level and adrenal pituitary hypothalamic: 1
    • acth cortisol level and adrenal thyroid: 1
    • acth cortisol response and adrenal insufficiency: 1, 2, 3, 4
    • acth cortisol response and adrenal pituitary: 1, 2, 3
    • acth cortisol response and adrenal pituitary hypothalamic: 1, 2, 3
    • acth response and acute respiratory syndrome: 1
    • acth response and adrenal insufficiency: 1, 2, 3, 4, 5
    • acth response and adrenal pituitary: 1, 2, 3, 4, 5
    • acth response and adrenal pituitary hypothalamic: 1, 2, 3, 4, 5
    • acth response and adrenal thyroid: 1, 2